As we mark Women's History Month 2025, TravelPulse is once again taking a moment to acknowledge the substantial contributions ...

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...

Globus Medical (GMED) announced the completion of its previously disclosed acquisition of Nevro (NVRO). The acquisition of Nevro further ...

Learn more about whether Globus Medical, Inc. or Inspire Medical Systems, Inc. is a better investment based on AAII's A+ ...

Learn more about whether Globus Medical, Inc. or iRhythm Technologies, Inc. is a better investment based on AAII's A+ ...

Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the company, Marketbeat reports.

Globus Medical GMED has outperformed the market over the past 10 years by 1.08% on an annualized basis producing an average annual return of 11.62%. Currently, Globus Medical has a market ...

Globus Medical, Inc. has a one year low of $49.33 and a one year high of $94.93. The company’s 50 day moving average price is $83.16 and its 200 day moving average price is $79.92.

AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of ...

In the preceding three months, 5 analysts have released ratings for Globus Medical (NYSE:GMED), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their ...